A Study to Evaluate Safety, Pharmacokinetics and Anti-Tumor Activity of RO7300490, as Single Agent or in Combination With Atezolizumab in Participants With Advanced Solid Tumors
Clinical trial NCT04857138 · COMPLETED
Trial details
- NCT number
- NCT04857138
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-18
- Primary completion
- 2024-01-18
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.